findmyKOL
Clinical trialNCT06092892RecruitingPhase 2Interventional

IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases

SponsorAlice ChungEnrollment45Axilla; BreastAxillary Nodal DiseaseBreast CancerFemale Breast CancerMastectomy; LymphedemaTumor, Breast
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute

    Los Angeles, California, United States

    Alice Chung, MDAmin Mirhadi, MDArmando Giuliano, MDCatherine Dang, MDFarin Amersi, MDJulie Jang, MDKjirsten Carlson, MDMarissa Boyle, MDMichele Burnison, MDScott Karlan, MDStephen Shiao, MD PhD
    Recruiting
  • Cs Cancer at Huntington Cancer Center

    Pasadena, California, United States

    Alicia Terando, MDAmy Polverini, MDJeannie Shen, MD
    Recruiting
  • Cs Cancer at Valley Oncology Medical Group

    Tarzana, California, United States

    Lauren DeStefano, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
7 Apr 2024
Primary completion
30 Apr 2031
Completion
30 Apr 2031
Last update posted
11 May 2026
Registered enrollment
45
Registry id
NCT06092892
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.